<DOC>
	<DOCNO>NCT02599532</DOCNO>
	<brief_summary>The nephrotic syndrome ( NS ) characterize proteinuria hypoalbuminemia , patient nephrotic syndrome know hypercoaguable increase incidence venous thromboembolism necessitate anticoagulation . While classically warfarin use anticoagulant NS , new oral anticoagulant , apixaban , increasingly use treat venous thromboembolism ( VTE ) general population . It unknown hypoalbuminemia proteinuria affect pharmacokinetics pharmacodynamics apixaban . This study investigate pharmacokinetics pharmacodynamics apixaban nephrotic syndrome .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Apixaban Nephrotic Syndrome</brief_title>
	<detailed_description>This parallel arm , single-dose pilot study pharmacokinetics apixaban adult nephrotic syndrome . Goal enrollment twenty subject non-diabetic nephropathy albumin ≤ 2.8 g/dl ten healthy control subject without nephrotic syndrome . Each subject administer single dose apixaban 10 mg . Plasma drug concentration level plasma anti-Xa activity level measure 3 , 6 , 24 hour drug administration order determine maximum plasma concentration apixaban , area curve , half-life apixaban set hypoalbuminemia proteinuria due nephrotic syndrome . Apixaban level measure via liquid-chromatography spectrometry mass . Additionally , thrombin generation measure 0 , 3 , 6 , 24 hour .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Nephrotic Syndrome</mesh_term>
	<mesh_term>Nephrosis</mesh_term>
	<mesh_term>Apixaban</mesh_term>
	<criteria>1879 year old nephrotic syndrome subject : hypoalbuminemia define albumin &lt; 2.8 mg/dl attributable nondiabetic nephrotic syndrome Creatinine ≥ 1.5 AND weight ≤ 60kg dialysis baseline prolong prothrombin time ( PT ) / international normalize ratio ( INR ) , partial thromboplastin time ( PTT ) platelets less 100,000 history gastrointestinal bleed history intracranial bleed history stroke use follow medication within past 14 day : inducer cytochrome P450 3A4 ( CYP3A4 ) : rifampin , carbamazepine , phenytoin , St. John 's wort strong inhibitor cytochrome P450 3A4 ( CYP3A4 ) : ketoconazole , ritonavir , clarithromycin antiplatelet and/ anticoagulant agent : heparin , aspirin , clopidogrel , prasugrel , nonsteroidal antiinflammatory medicaitons , warfarin selective serotonin reuptake inhibitor ( SSRI ) serotoninnorepinephrine reuptake inhibitor ( SNRI ) pregnancy/ breastfeed liver disease lupus diabetic nephropathy congestive heart failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Apixaban</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
</DOC>